GlaxoSmithKline Pharmaceuticals Limited's total assets for Q1 2024 were ₹0.00, a decrease of -100.00% from the previous quarter. IN:GLAXO total liabilities were ₹-17.78B for the fiscal quarter, a -198.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Total Assets
₹ 35.57B
₹ 33.27B
₹ 46.33B
₹ 31.13B
₹ 31.36B
Total Liabilities
₹ 17.79B
₹ 15.85B
₹ 19.70B
₹ 16.14B
₹ 13.15B
Total Equity Gross Minority
₹ 17.78B
₹ 17.41B
₹ 26.63B
₹ 14.99B
₹ 18.21B
Other Metrics
₹ ―
₹ ―
₹ ―
₹ ―
₹ ―
Currency in INR
GlaxoSmithKline Pharmaceuticals Limited Debt to Assets